oxigen linde 100%
linde gas a.s. - republica ceha - oxigenum - gaz medicinal criogenic - 100% - alte preparate terapeutice gaze medicinale
rizmoic
shionogi b.v. - naldemedine tosilate - constipație - medicamente pentru constipație, periferice antagoniști ai receptorilor opioizi - rizmoic este indicat pentru tratamentul constipației induse de opioide (oic) la pacienții adulți care au fost tratați anterior cu un laxativ.
clensia
sigmar italia s.p.a. - italia - combinatii - pulb. pt. susp. orala - laxative laxative osmotice
cutie inox pentru sterilizat instrumente, de 22, 34, 42 cm, cod b0080, b0081, b0082
sc itm amiro sa -
casoleta pentru sterilizare, de 16, 19, 24, 29, 34, 39, cod b0029, b0030, b0031, b0032, b0033, b0221
sc itm amiro sa -
sitagliptina biogaran 25 mg
recipharm fontaine - franta - sitagliptinum - compr. film. - 25mg - antidiabetice orale inhibitori ai dipeptidil peptidazei 4 (dpp-4)
zinzibet 25 mg
recipharm fontaine - franta - sitagliptinum - compr. film. - 25mg - antidiabetice orale inhibitori ai dipeptidil peptidazei 4 (dpp-4)
skyrizi
abbvie deutschland gmbh & co. kg - risankizumab - psoriasis; arthritis, psoriatic - imunosupresoare - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). crohn's diseaseskyrizi is indicated for the treatment of adult patients with moderately to severely active crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.
clensia
sigmar italia s.p.a. - italia - combinatii - pulb. pt. susp. orala - laxative laxative osmotice
isturisa
recordati rare diseases - osilodrostat fosfat - sindromul cushing - corticosteroizi pentru uz sistemic - isturisa este indicat pentru tratamentul endogene sindromul cushing la adulți.